We are live on
!
Find out more
SGK
Steigerwald Gordon & Koch Portfolio holdings
AUM
$974M
1-Year Est. Return
13.43%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+13.43%
3 Year Est. Return
+53.19%
5 Year Est. Return
+76.04%
10 Year Est. Return
+263.05%
AUM
$220M
AUM Growth
+$4.66M
(+2.2%)
Cap. Flow
+$5.76M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
33.89%
Holding
53
New
2
Increased
31
Reduced
12
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APA Corp
APA
|
+$606K |
| 2 |
ABB
ABB Ltd
ABB
|
+$505K |
| 3 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$474K |
| 4 |
Check Point Software Technologies
CHKP
|
+$473K |
| 5 |
ExxonMobil
XOM
|
+$401K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$655K |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$328K |
| 3 |
Walmart Inc
WMT
|
+$206K |
| 4 |
Apple
AAPL
|
+$106K |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$104K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.93% |
| 2 | Healthcare | 19.86% |
| 3 | Energy | 11.14% |
| 4 | Consumer Staples | 8.24% |
| 5 | Materials | 6.02% |
Similar funds
UIC
TCCM
ADIC
SAM
DACS
GFP
KL
JWM
Steigerwald Gordon & Koch's Q2 2015 Portfolio in Review
As of Q2 2015, Steigerwald Gordon & Koch held 53 positions worth $220M, up 2.2% from $215M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Steigerwald Gordon & Koch's Q2 2015 filing shows 2 new, 31 increased, 12 reduced and 2 closed positions. Its largest new stake was HP: 23,187 shares worth $316K. The largest sale was Elevance Health, an estimated $655K.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Energy.
- Steigerwald Gordon & Koch's largest Q2 2015 buy was HP: 23,187 shares worth $316K.
- Steigerwald Gordon & Koch added most to APA Corp in Q2 2015, an estimated $606K increase.
- Steigerwald Gordon & Koch's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $655K.
- Steigerwald Gordon & Koch fully exited Ligand Pharmaceuticals in Q2 2015, selling an estimated $328K.
- Steigerwald Gordon & Koch's ten largest holdings make up 34% of its $220M portfolio in Q2 2015.
- Steigerwald Gordon & Koch opened 2 new positions and closed 2 in Q2 2015.
- Steigerwald Gordon & Koch's portfolio value rose 2.2% quarter-over-quarter to $220M.
Based on Steigerwald Gordon & Koch's 13F filing for Q2 2015, filed 13 Sep 2018.